News Releases

For immediate release

HYDROXYCHLOROQUINE SIDE EFFECTS POTENTIALLY MITIGATED BY TRANSDERMAL DELIVERY

April 21, 2020 12:05 AM

Codebase Investee has secured rights to develop a Transdermal Hydroxychloroquine Drug Delivery System to offer controlled, prescribed dosage mitigating side effects

HYDROXYCHLOROQUINE TREATMENT FOR COVID-19 BENEFITS SOUGHT IN GLOBAL RESEARCH EFFORT TO ESTABLISH EFFICACY

April 20, 2020 6:30 AM

Codebase investee has secured rights to Transdermal Hydroxychloroquine Drug Delivery System

CODEBASE VENTURES INC. ANNOUNCES $1.5 MILLION FINANCING AND FIRST CLOSING OF FINANCING

April 16, 2020 2:30 PM

CODEBASE TO INVEST IN COMPANY DEVELOPING HYDROXYCHLOROQUINE TRANSDERMAL TREATMENT

April 16, 2020 12:01 AM

CODEBASE PROVIDES UPDATE ON ITS HOLDINGS AND NEAR-TERM INVESTMENT PRIORITIES

April 03, 2020 12:05 AM

CODE VENTURES INC. EXTENDS EXPIRY DATE OF CERTAIN WARRANTS

March 05, 2020 1:00 PM

CODEBASE VENTURES INC. CLOSES NON-BROKERED PRIVATE PLACEMENT

February 25, 2020 3:02 PM

CODE FINALIZES STRATEGIC INVESTMENT IN MOBILE GAME APP TRAD3R

February 20, 2020 12:01 AM

WITH 4.3 MILLION TOTAL ACTIVE USERS, THE TRAD3R APP GAMIFIES TRADING OF STOCKS, SPORTS, CELEBRITIES AND FRIENDS FOR MILLENIALS AND GEN Z’S

ARCOLOGY LAUNCHES TESTING OF ETHEREUM APPLICATIONS

February 19, 2020 12:05 AM

ARCOLOGY TO DEMONSTRATE ITS ADVANTAGES WITH UTILIZING ONE OF THE MOST SUCCESSFUL GAMES ON ETHEREUM

CODE VENTURES INC. EXTENDS EXPIRY DATE OF CERTAIN WARRANTS

February 14, 2020 1:00 PM